112 related articles for article (PubMed ID: 32665382)
1. Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review.
Hájek R; Gonzalez-McQuire S; Szabo Z; Delforge M; DeCosta L; Raab MS; Bouwmeester W; Campioni M; Briggs A
BMJ Open; 2020 Jul; 10(7):e034209. PubMed ID: 32665382
[TBL] [Abstract][Full Text] [Related]
2. Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting.
Bouwmeester W; Briggs A; van Hout B; Hájek R; Gonzalez-McQuire S; Campioni M; DeCosta L; Brozova L
Oncol Ther; 2019 Dec; 7(2):141-157. PubMed ID: 32699987
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma.
Hájek R; Delforge M; Raab MS; Schoen P; DeCosta L; Spicka I; Radocha J; Pour L; Gonzalez-McQuire S; Bouwmeester W
Br J Haematol; 2019 Nov; 187(4):447-458. PubMed ID: 31388996
[TBL] [Abstract][Full Text] [Related]
4. Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies.
Radocha J; Maisnar V; Pour L; Špička I; Minařík J; Szeligová L; Pavlíček P; Jungová A; Krejčí M; Pika T; Straub J; Brožová L; Stejskal L; Heindorfer A; Jindra P; Kessler P; Mikula P; Sýkora M; Wróbel M; Jarkovský J; Hájek R
Cancer Med; 2018 Aug; 7(8):4132-4145. PubMed ID: 29931775
[TBL] [Abstract][Full Text] [Related]
5. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
6. Understanding mortality in multiple myeloma: Findings of a European retrospective chart review.
Mohty M; Cavo M; Fink L; Gonzalez-McQuire S; Leleu H; Mateos MV; Raab MS; Schoen P; Yong K
Eur J Haematol; 2019 Aug; 103(2):107-115. PubMed ID: 31112311
[TBL] [Abstract][Full Text] [Related]
7. Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy.
Gonzalez-McQuire S; Yong K; Leleu H; Mennini FS; Flinois A; Gazzola C; Schoen P; Campioni M; DeCosta L; Fink L
J Med Econ; 2018 May; 21(5):450-467. PubMed ID: 29278014
[TBL] [Abstract][Full Text] [Related]
8. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
[TBL] [Abstract][Full Text] [Related]
9. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
[TBL] [Abstract][Full Text] [Related]
10. GCRS: A hybrid graph convolutional network for risk stratification in multiple myeloma cancer patients.
Sagar D; Aggarwal P; Farswan A; Gupta R; Gupta A
Comput Biol Med; 2022 Oct; 149():106048. PubMed ID: 36113255
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma: practice patterns across Europe.
Raab MS; Cavo M; Delforge M; Driessen C; Fink L; Flinois A; Gonzalez-McQuire S; Safaei R; Karlin L; Mateos MV; Schoen P; Yong K
Br J Haematol; 2016 Oct; 175(1):66-76. PubMed ID: 27291397
[TBL] [Abstract][Full Text] [Related]
12. Patient Characteristics and Outcomes of Relapsed/Refractory Multiple Myeloma in Patients Treated with Proteasome Inhibitors in Germany.
Steinmetz HT; Singh M; Lebioda A; Gonzalez-McQuire S; Rieth A; Schoehl M; Poenisch W
Oncol Res Treat; 2020; 43(9):449-459. PubMed ID: 32694243
[TBL] [Abstract][Full Text] [Related]
13. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z
Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086
[TBL] [Abstract][Full Text] [Related]
14. Centrosome associated genes pattern for risk sub-stratification in multiple myeloma.
Kryukov F; Nemec P; Radova L; Kryukova E; Okubote S; Minarik J; Stefanikova Z; Pour L; Hajek R
J Transl Med; 2016 May; 14(1):150. PubMed ID: 27234807
[TBL] [Abstract][Full Text] [Related]
15. Development of a Machine Learning Model for Survival Risk Stratification of Patients With Advanced Oral Cancer.
Tseng YJ; Wang HY; Lin TW; Lu JJ; Hsieh CH; Liao CT
JAMA Netw Open; 2020 Aug; 3(8):e2011768. PubMed ID: 32821921
[TBL] [Abstract][Full Text] [Related]
16. Automated Fall Detection Algorithm With Global Trigger Tool, Incident Reports, Manual Chart Review, and Patient-Reported Falls: Algorithm Development and Validation With a Retrospective Diagnostic Accuracy Study.
Dolci E; Schärer B; Grossmann N; Musy SN; Zúñiga F; Bachnick S; Simon M
J Med Internet Res; 2020 Sep; 22(9):e19516. PubMed ID: 32955445
[TBL] [Abstract][Full Text] [Related]
17. Bone complications in patients with multiple myeloma in five European countries: a retrospective patient chart review.
Mateos MV; Fink L; Koneswaran N; Intorcia M; Giannopoulou C; Niepel D; Cavo M
BMC Cancer; 2020 Mar; 20(1):170. PubMed ID: 32126974
[TBL] [Abstract][Full Text] [Related]
18. Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review.
Brandenburg NA; Phillips S; Wells KE; Woodcroft KJ; Amend KL; Enger C; Oliveria SA
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):256-263. PubMed ID: 30719785
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification of thymic epithelial tumors by using a nomogram combined with radiomic features and TNM staging.
Shen Q; Shan Y; Xu W; Hu G; Chen W; Feng Z; Pang P; Ding Z; Cai W
Eur Radiol; 2021 Jan; 31(1):423-435. PubMed ID: 32757051
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M
Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
